218
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Detection and Control of Biofilm Formation by Staphylococcus aureus from Febrile Neutropenic Patient

ORCID Icon, & ORCID Icon
Pages 3091-3101 | Published online: 07 Sep 2020

References

  • Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol Pract. 2019;15(1):19–24. doi:10.1200/JOP.18.0026930629902
  • Ko KI, Root CM, Lindsay SA, et al. Starvation promotes concerted modulation of appetitive olfactory behavior via parallel neuromodulatory circuits. Elife. 2015;4:e08298. doi:10.7554/eLife.08298
  • Van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167(4):441–452. doi:10.1111/bjh.1311325196917
  • de Souza Viana L, Serufo JC, da Costa Rocha MO, Costa RN, Duarte RC. Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer. 2008;16(7):841–846. doi:10.1007/s00520-007-0347-317960431
  • Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(6):794–810. doi:10.1200/JCO.2012.45.866123319691
  • Yadegarynia D, Fatemi A, Mahdizadeh M, Movahhed RK, Alizadeh MA. Current spectrum of bacterial infections in patients with nosocomial fever and neutropenia. Caspian J Intern Med. 2013;4(3):698.24009963
  • Coates R, Moran J, Horsburgh MJ. Staphylococci: colonizers and pathogens of human skin. Future Microbiol. 2014;9(1):75–91. doi:10.2217/fmb.13.14524328382
  • Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One. 2013;8(1). doi:10.1371/annotation/e199ebcc-0bc1-4be1-ad91-ad2a8c0c9382
  • Clarisse T, Michèle S, Olivier T, et al. Detection and quantification of staphylococcal enterotoxin A in foods with specific and sensitive polyclonal antibodies. Food Control. 2013;32(1):255–261. doi:10.1016/j.foodcont.2012.11.021
  • Dunsing V, Irmscher T, Barbirz S, Chiantia S. Purely polysaccharide-based biofilm matrix provides size-selective diffusion barriers for nanoparticles and bacteriophages. Biomacromolecules. 2019;20(10):3842–3854. doi:10.1021/acs.biomac.9b0093831478651
  • Diemond-Hernández B, Solórzano-Santos F, Leaños-Miranda B, Peregrino-Bejarano L, Miranda-Novales G. Production of icaADBC-encoded polysaccharide intercellular adhesin and therapeutic failure in pediatric patients with staphylococcal device-related infections. BMC Infect Dis. 2010;10(1):68. doi:10.1186/1471-2334-10-6820230642
  • O’Neill E, Pozzi C, Houston P, et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol. 2008;190(11):3835–3850. doi:10.1128/JB.00167-0818375547
  • Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 2008;4:4. doi:10.1371/journal.ppat.1000052
  • Tribedi P, Sil AK. Cell surface hydrophobicity: a key component in the degradation of polyethylene succinate by P seudomonas sp. AKS 2. J Appl Microbiol. 2014;116(2):295–303. doi:10.1111/jam.1237524165295
  • Quinn L, Barros C, Vitale S, Casey E. Extraction and identification of components of the biofilm matrix in Pseudomonas species biofilms. Access Microbiol. 2019;1(1A):386. doi:10.1099/acmi.ac2019.po0219
  • Rendueles O, Kaplan JB, Ghigo JM. Antibiofilm polysaccharides. Environ Microbiol. 2013;15(2):334–346. doi:10.1111/j.1462-2920.2012.02810.x22730907
  • Hentzer M, Riedel K, Rasmussen TB, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology. 2002;148(1):87–102. doi:10.1099/00221287-148-1-8711782502
  • Melo PDC, Ferreira LM, Nader Filho A, Zafalon LF, Vicente HIG, Souza VD. Comparison of methods for the detection of biofilm formation by Staphylococcus aureus isolated from bovine subclinical mastitis. Braz J Microbiol. 2013;44(1):119–124. doi:10.1590/S1517-8382201300500003124159293
  • Wayne PA. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing; 2011.
  • Cheville NF, Stasko J. Techniques in electron microscopy of animal tissue. Vet Pathol. 2014;51(1):28–41. doi:10.1177/030098581350511424114311
  • Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD Genes and slime production in a collection of Staphylococcal strains from catheter-associated infections. J Clin Microbiol. 2001;39(6):2151–2156. doi:10.1128/JCM.39.6.2151-2156.200111376050
  • Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56–e93. doi:10.1093/cid/cir07321258094
  • Boyce JM, Havill NL, Kohan C, Dumigan DG, Ligi CE. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol. 2004;25(5):395–401. doi:10.1086/50241215188845
  • Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur A. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009;31(9):623. doi:10.1097/MPH.0b013e3181b1edc619644403
  • Bodey GP, Buckley M, Sathe Y, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328–340. doi:10.7326/0003-4819-64-2-3285216294
  • Glauser M, Boogaerts M, Cordonnier C, Palmblad J, Martino P. Empiric therapy of bacterial infections in severe neutropenia. Clin Microbiol Infect. 1997;3:s77–s86. doi:10.1111/j.1469-0691.1997.tb00648.x
  • Durnaa B, Dzierzanowska D. Infection in neutropenic cancer patients–etiology, microbiological diagnostics, treatment. Wiadomoscilekarskie. 2006;59(7–8):506–511.
  • Darwish SF, Asfour HA. Investigation of biofilm forming ability in Staphylococci causing bovine mastitis using phenotypic and genotypic assays. Sci World J. 2013;2013:1–9. doi:10.1155/2013/378492
  • El-Hendi AA, El-Fotouh MAA, El-Shalakany AH, Shalaby HM. Biofilm formation by blood stream staphylococcal isolates from febrile neutropenic cancer patients. Menoufia Med J. 2016;29(2):349. doi:10.4103/1110-2098.192435
  • Seif-El-Din SS, El-Rehewy MS, Ghazaly MM, Abd-Elhamid MH. Biofilm formation by blood stream Staphylococcal isolates from febrile pediatric cancer patients at South Egypt Cancer Institute. The Journal of American Science. 2011;7(1):674–686
  • Percival SL, Malic S, Cruz H, Williams DW. Introduction to biofilms In: Percival SL, Knottenbelt DC, Christine A, editors Biofilms and Veterinary Medicine. Berlin, Heidelberg: Springer; 2011:41–68.
  • Shalamanov DS. Chlorhexidine gluconate-induced morphological changes in gram negative microorganisms. Biotechnol Biotechnol Equip. 2005;19(1):121–124. doi:10.1080/13102818.2005.10817165
  • Bhaskar BH, Mulki SS, Joshi S, Adhikary R, Venkatesh BM. Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital. Indian J Crit Care Med 2019;23(2):61–66. doi:10.5005/jp-journals-10071-23118
  • Hartmann M, Berditsch M, Hawecker J, Ardakani MF, Gerthsen D, Ulrich AS. Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob Agents Chemother. 2010;54(8):3132–3142. doi:10.1128/AAC.00124-1020530225
  • Mirzajani F, Ghassempour A, Aliahmadi A, Esmaeili MA. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol. 2011;162(5):542–549. doi:10.1016/j.resmic.2011.04.00921530652
  • El-Mahallawy HA, Loutfy SA, El-Wakil M, El-Al AKA, Morcos H. Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients. Pediatr Blood Cancer. 2009;52(7):824–828. doi:10.1002/pbc.2196419214976
  • Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumors. Eur J Cancer 2011;47(1):8–32. doi:10.1016/j.ejca.2010.10.013